MediciNova Research And Ddevelopement To Revenue from 2010 to 2025

MNOV Stock  USD 2.10  0.01  0.47%   
MediciNova Research And Ddevelopement To Revenue yearly trend continues to be fairly stable with very little volatility. Research And Ddevelopement To Revenue is projected to decline to 6.18 this year. Research And Ddevelopement To Revenue is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. View All Fundamentals
 
Research And Ddevelopement To Revenue  
First Reported
2010-12-31
Previous Quarter
6.51
Current Value
6.18
Quarterly Volatility
5.47489042
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.9 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
  
Check out the analysis of MediciNova Correlation against competitors.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

Latest MediciNova's Research And Ddevelopement To Revenue Growth Pattern

Below is the plot of the Research And Ddevelopement To Revenue of MediciNova over the last few years. It is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. MediciNova's Research And Ddevelopement To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
Research And Ddevelopement To Revenue10 Years Trend
Slightly volatile
   Research And Ddevelopement To Revenue   
       Timeline  

MediciNova Research And Ddevelopement To Revenue Regression Statistics

Arithmetic Mean4.76
Geometric Mean3.24
Coefficient Of Variation115.02
Mean Deviation3.38
Median2.11
Standard Deviation5.47
Sample Variance29.97
Range22.5221
R-Value(0.33)
Mean Square Error28.74
R-Squared0.11
Significance0.23
Slope(0.41)
//window.location = "/error404.html";